Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans.

Saved in:
Bibliographic Details
Title: Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans.
Authors: Schuster DJ; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, USA., Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Mielke D; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Seaton KE; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Brackett C; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Li K; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Shen X; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Wesley MS; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Eisel N; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Yates NL; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Zhang L; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Sawant S; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Stanfield-Oakley S; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA., Sholukh AM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Germain RS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Li X; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hu J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Premkumar L; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA., Gallardo-Cartagena JA; Universidad Nacional Mayor de San Marcos, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Lima, Peru., Randhawa AK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Dennison SM; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Hural JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Ferrari G; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA., Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Tomaras GD; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, USA.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA.
Source: IScience [iScience] 2026 Mar 09; Vol. 29 (4), pp. 115277. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2026.115277